These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 44910)

  • 1. Comparative in vitro microbiological activity and stability of cefaclor.
    Gillett AP; Andrews JM; Wise R
    Postgrad Med J; 1979; 55 Suppl 4():9-11. PubMed ID: 44910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological and in vitro comparison of three oral cephalosporins.
    Wise R; Andrews JM; Dean S; Welling PG; Kendall MJ
    J Antimicrob Chemother; 1979 Sep; 5(5):601-7. PubMed ID: 115833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ; Washington JA
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
    Powell M; Williams JD
    J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)].
    Braveny I
    Infection; 1979; 7 Suppl 6():532-9. PubMed ID: 317812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
    Levison ME; Santoro J; Agarwal BN
    Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimicrobial activity of cephalexin against old and new pathogens.
    Jones RN; Preston DA
    Postgrad Med J; 1983; 59 Suppl 5():9-15. PubMed ID: 6364091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMY 28100, a new oral cephalosporin.
    Leitner F; Pursiano TA; Buck RE; Tsai YH; Chisholm DR; Misiek M; Desiderio JV; Kessler RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):238-43. PubMed ID: 3105449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN; Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
    Sinai R; Hammerberg S; Marks MI; Pai CH
    Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T; Jalanko E; Scheinin L; Renkonen OV
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size.
    Levin RM; Azimi PH; Dunphy MG
    Antimicrob Agents Chemother; 1982 Nov; 22(5):923-5. PubMed ID: 6983863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefaclor in the treatment of uncomplicated gonococcal urethritis.
    Harrison WO
    Postgrad Med J; 1979; 55 Suppl 4():85-7. PubMed ID: 121455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine.
    Silver MS; Counts GW; Zeleznik D; Turck M
    Antimicrob Agents Chemother; 1977 Nov; 12(5):591-6. PubMed ID: 921255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.